| 1 |
35314692 | A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients. | 2022 Mar 21 |
1 |
| 2 |
32829374 | Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells. | 2020 Aug 23 |
1 |
| 3 |
33000256 | Knockdown of SERPINE1 reverses resistance of triple‑negative breast cancer to paclitaxel via suppression of VEGFA. | 2020 Nov |
1 |
| 4 |
33269821 | Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway. | 2020 Nov |
2 |
| 5 |
30682083 | Synthetic lethality guiding selection of drug combinations in ovarian cancer. | 2019 |
1 |
| 6 |
31432702 | Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. | 2019 Dec |
1 |
| 7 |
28681330 | Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes. | 2018 Jan |
1 |
| 8 |
29031923 | DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition. | 2018 Jan |
1 |
| 9 |
29242937 | Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. | 2018 Feb 1 |
1 |
| 10 |
29403275 | Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo. | 2018 |
7 |
| 11 |
29532357 | Novel approach for a PTX/VEGF dual drug delivery system in cardiovascular applications-an innovative bulk and surface drug immobilization. | 2018 Jun |
3 |
| 12 |
29641777 | The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion. | 2018 Mar |
1 |
| 13 |
30013393 | The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance. | 2018 |
1 |
| 14 |
30420976 | Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer. | 2018 Dec 18 |
1 |
| 15 |
28106938 | Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation. | 2017 Apr |
3 |
| 16 |
28753317 | Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy. | 2017 Sep 5 |
2 |
| 17 |
31271140 | Efficient Suppression of Liver Metastasis Cancers by Paclitaxel Loaded Nanoparticles in PDLLA-PEG-PDLLA Thermosensitive Hydrogel Composites. | 2017 Nov 1 |
1 |
| 18 |
27059733 | Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. | 2016 Sep |
1 |
| 19 |
27198186 | Biology and treatment of cervical adenocarcinoma. | 2016 Apr |
1 |
| 20 |
27272808 | Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion. | 2016 Jun |
1 |
| 21 |
27648354 | Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment. | 2016 |
1 |
| 22 |
27893676 | Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion. | 2016 Nov |
1 |
| 23 |
27992556 | Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study. | 2016 |
3 |
| 24 |
25855930 | The mechanism and inhibitory effect of recombinant human P53 adenovirus injection combined with paclitaxel on human cervical cancer cell HeLa. | 2015 |
1 |
| 25 |
25947567 | The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines. | 2015 Aug |
1 |
| 26 |
26004370 | Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles. | 2015 |
1 |
| 27 |
26118713 | Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer. | 2015 |
1 |
| 28 |
26287605 | Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. | 2015 Sep 8 |
2 |
| 29 |
24520227 | Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. | 2014 Jan |
1 |
| 30 |
24749390 | Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery. | 2014 Jun |
1 |
| 31 |
24864163 | Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review. | 2014 |
1 |
| 32 |
25122429 | Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study. | 2014 Sep |
1 |
| 33 |
25153728 | The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways. | 2014 Aug 15 |
3 |
| 34 |
25342321 | Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts. | 2014 Oct 23 |
1 |
| 35 |
23340303 | Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial. | 2013 Mar 1 |
1 |
| 36 |
23389639 | The pharmacological bases of the antiangiogenic activity of paclitaxel. | 2013 Jul |
1 |
| 37 |
23401453 | Markers of response for the antiangiogenic agent bevacizumab. | 2013 Mar 20 |
1 |
| 38 |
23426648 | Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts. | 2013 Mar |
1 |
| 39 |
23610448 | A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs. | 2013 May 1 |
2 |
| 40 |
23925664 | Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion. | 2013 |
2 |
| 41 |
22012632 | Bevacizumab in the treatment of metastatic breast cancer: friend or foe? | 2012 Feb |
2 |
| 42 |
22481432 | Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed? | 2012 Mar |
1 |
| 43 |
22734125 | Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. | 2012 Sep |
2 |
| 44 |
22743248 | Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. | 2012 Sep |
1 |
| 45 |
22757735 | Novel antiangiogenic therapies in ovarian cancer. | 2012 Jul |
1 |
| 46 |
22969865 | Knockdown of vascular endothelial cell growth factor expression sensitizes U251 glioma cells to liposomal paclitaxel and radiation treatment in vitro. | 2012 Feb |
4 |
| 47 |
23481572 | Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: a tentative relationship between drug type and tumor cell type response. | 2012-2013 |
2 |
| 48 |
20495920 | In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines. | 2011 Mar |
1 |
| 49 |
21563601 | [Retraction: Effects of oxymatrine injection combined with low-dose paclitaxel on mRNA and protein expressions of vascular endothelial growth factor and CXC chemokine receptor 4 in human gastric carcinoma SGC-7901 cells]. | 2011 Apr |
1 |
| 50 |
21565129 | Retraction: "Effects of oxymatrine injection combined with low-dose paclitaxel on mRNA and protein expressions of vascular endothelial growth factor and CXC chemokine receptor 4 in human gastric carcinoma SGC-7901 cells". | 2011 Apr |
1 |